US Earnings Financial Results SEC Filings — August 31, 2026

31-08-2026

Royale Energy reported a net loss of $819,629 for Q1 2026, widening from a $681,951 loss in Q1 2025, driven by a sharp increase in oil and gas lease operating expenses. While total revenue grew 15.6% to $563,358, primarily from higher oil and condensate sales, operating expenses rose 14.9%, outpacing revenue growth. The company's cash position declined significantly, and its accumulated deficit and total stockholders' deficit both worsened.

• · Natural gas sales declined 44.4% YoY to $35,324, while NGL sales surged to $8,356 from $1,150.
• · Oil and gas lease operating expenses more than doubled, increasing 118.3% YoY to $400,281.
• · The company acquired producing properties for $200,000 in Q1 2026, with no such acquisition in Q1 2025.
• · Proceeds from turnkey drilling programs decreased 9.2% YoY to $522,000.
• · Cash used in operating activities increased 70.3% YoY to $1,051,755.
• · Total liabilities increased to $31,053,929 from $30,393,268 at year-end 2025.
• · The company's money market funds decreased to $6,898,349 from $7,942,085 at December 31, 2025.
• · Basic and diluted loss per share remained flat at $(0.01).

31-08-2026

Greystone Logistics filed its annual report (10-K) for the fiscal year ended May 31, 2026. The financial statements show operating cash outflows of approximately $1.48 million and investing outflows of $1.97 million, offset by $2.42 million in financing inflows. The company maintains significant debt obligations totaling $13.1 million and operating lease commitments; while interest income fell sharply from $98,361 to $5,006, total other income dropped from $162,249 to $4,968.

• · The company owns two buildings within 30 miles of its primary facility, providing an additional 75,000 square feet of warehouse space used for warehousing inventory and grinding operations.
• · The company has identified a 'Going Concern and Management’s Plan' note in the financial statements, indicating potential uncertainties about its ability to continue.
• · Long-term debt of $10,875,914 has maturities: $1,296,609 within 1 year, $6,467,918 in 2-3 years, and $3,111,387 in 4-5 years.
• · The revolving loan of $2,200,000 is due within one year.
• · Operating lease obligations total $6,639,150, with $3,597,820 due beyond 5 years.

31-08-2026

Idaho Copper Corp (COPR) filed its 10-Q for the period ended July 31, 2026, reporting a net loss of $2.2M for the quarter and $3.7M for the six-month period, widening from losses of $0.8M and $1.5M in the prior-year periods. The company raised $16.5M through a stock sale and issued $1.4M in convertible notes, boosting cash from $24K to $12.1M and shifting stockholders' equity from a deficit of $6.5M to a positive $11.3M. However, operating expenses more than doubled to $1.1M (quarter) and $2.4M (six months), and the company still has zero revenue.

• · Revenue remains zero for all periods presented.
• · Interest expense increased to $392,232 (quarter) and $527,037 (six months) from $76,495 and $196,245 in prior-year periods.
• · Amortization of debt discount was $770,844 (quarter) and $807,645 (six months); none in prior year.
• · Stock-based compensation decreased to $318,026 (quarter) and $663,026 (six months) from $597,500 and $875,000.
• · Net cash used in operating activities was $3.3M (six months) vs. $0.3M in prior year.
• · The company acquired mining claims valued at $2.0M, partly through issuance of 309,278 common shares for $1.5M.
• · Convertible notes payable resulted in issuance of warrants valued at $780,854.
• · Stock price range during the period: $1.40 – $4.00.

31-08-2026

Biomerica Inc (BMRA) filed its 10-K annual report for the fiscal year ended May 31, 2026, reporting a 16% decline in total revenue to $4.453M from $5.311M in FY 2025. Revenue decreased across all geographic segments, with the Middle East experiencing the steepest drop (-29%). Selling, General and Administrative expenses rose 6% to $4.894M, now exceeding total revenue at 110% of revenues, while Research and Development spending was cut by 23% to $788K. Cash and cash equivalents nearly halved to $1.308M from $2.399M, and working capital fell to $1.535M from $3.135M. The company explicitly states it needs to raise additional capital and continue as a going concern.

• · SG&A expenses as a percentage of total revenue rose to 110% in FY 2026 from 87% in FY 2025, indicating operating costs exceed revenue.
• · R&D spending was cut by 23% to $788K, reducing its share of revenue from 19% to 18%.
• · South America revenue increased 87.5% to $15K, but from a very low base and remains negligible at 0% of total revenue.
• · The company explicitly cites the need to raise additional capital through equity and/or debt markets to meet current obligations and fund operations, and acknowledges limitations from SEC regulations on equity issuance.
• · Key risk factors include reliance on CMS payment rates, regulatory clearances, competition, reimbursement changes, tariffs, and geopolitical instability.

31-08-2026

CytoDyn Inc. reported a net loss of $42.7M for fiscal year 2026, a sharp reversal from net income of $3.7M in fiscal 2025, driven by a $15.4M legal settlement loss and a $32.6M swing in R&D expenses (which went from a negative $16.9M to $15.7M). Total operating expenses surged 499% to $38.6M, while operating cash flow worsened to negative $17.3M from negative $8.8M. The company's accumulated deficit deepened to $930.5M, and stockholders' deficit grew to $109.7M, though it raised $21.4M in private offerings and $9.5M from convertible note repayments.

• · Total shares reserved for future uses as of May 31, 2026: 585.2 million, including 306.4 million from warrant exercises, 115.5 million under Standby Equity Purchase Agreement, and 49.0 million reserved for legal settlement.
• · Total liabilities increased 8.4% to $123.7M as of May 31, 2026, driven by a $16.7M increase in accrued liabilities and compensation.
• · Stock-based compensation was $1.6M in fiscal 2026, up from $1.5M in fiscal 2025.
• · Interest income declined 55% to $0.3M in fiscal 2026 from $0.6M in fiscal 2025.
• · The company had no income tax benefit in either fiscal year.

31-08-2026

Legend Spices, Inc. reported a net loss of $4,950 for the six months ended June 30, 2026, compared to a net loss of $8,861 in the same period of 2025, showing an improvement of 44.1%. However, the company generated zero sales revenue in both the current and prior-year periods, and its total liabilities exceeded total assets, resulting in a stockholders' deficit of $22,475 as of June 30, 2026, up from $17,525 at year-end 2025.

• · Sales were $0 for both the 3-month and 6-month periods ended June 30, 2026, compared to $644 in the prior-year 6-month period.
• · Professional fees were $4,950 for the 6 months ended June 30, 2026, down from $5,567 in the prior-year period.
• · Cash balance was $0 at both June 30, 2026 and December 31, 2025.
• · Accumulated deficit increased to $132,962 as of June 30, 2026 from $128,012 at December 31, 2025.
• · The company had a net operating loss carryover deferred tax asset of $27,922, fully offset by a valuation allowance.

31-08-2026

Luvulis Corp reported its first-ever revenue of $833 for the three and six months ended July 31, 2026, compared to zero revenue in the prior-year periods. However, the company generated a net loss of $12,035 for the quarter and $34,434 for the six-month period, with operating expenses of $12,868 and $35,267 respectively. The company's cash position declined from $680 at January 31, 2026 to $312 at July 31, 2026, and stockholder's equity turned negative from $6,360 to ($28,074), driven by a large related party loan payable of $91,892.

• · The company had no operations in the prior-year periods (three and six months ended July 31, 2025), reporting zero revenue, zero expenses, and zero net loss.
• · Intangible assets, net increased from $0 at January 31, 2026 to $57,621 at July 31, 2026, reflecting capitalization of website and API development costs of $62,520.
• · Deferred revenue of $6,628 was recorded at July 31, 2026, compared to $0 at January 31, 2026.
• · Accounts payable decreased from $27,400 at January 31, 2026 to $0 at July 31, 2026.
• · Net cash used in operating activities for the six months ended July 31, 2026 was $85,227, entirely financed by related party advances of $84,859.
• · The company is a non-accelerated filer, small business, and emerging growth company, incorporated in Wyoming with headquarters in Warsaw, Poland.
• · The company's fiscal year ends January 31.

31-08-2026

Science Applications International Corp (SAIC) reported revenues of $1,880M for Q2 FY26 (three months ended July 31, 2026), up 6.3% from $1,769M in the prior-year quarter. However, net income declined 19.7% to $102M from $127M, driven by a $17M income tax expense versus a $19M benefit in the prior year. For the six-month period, revenues grew 3.8% to $3,786M and net income rose 11.3% to $217M, but operating cash flow improved to $273M from $222M.

• · Diluted EPS for Q2 FY26 was $2.38, down from $2.71 in Q2 FY25.
• · Diluted EPS for H1 FY26 was $5.00, up from $4.12 in H1 FY25.
• · Cash dividends of $0.37 per share were paid in Q2 FY26, consistent with prior year.
• · Stock repurchases totaled $91M in Q2 FY26 and $267M in H1 FY26, compared to $109M and $234M in the respective prior-year periods.
• · Total debt (current + non-current) was $2,485M at July 31, 2026, up from $2,487M at January 30, 2026.
• · Goodwill remained essentially flat at $2,943M.
• · Receivables increased to $996M from $853M at year-end, contributing to negative operating cash flow from receivables of -$143M in H1 FY26.

31-08-2026

Super Micro Computer, Inc. (SMCI) reported a strong fiscal year 2026 with net sales surging 77.8% to $39,063.1M, driven by continued demand for AI and server solutions. Net income more than doubled to $2,230.5M from $1,048.9M in FY2025, with diluted EPS rising to $3.26 from $1.68. However, gross margin continued to compress, declining to 10.8% from 11.1% in FY2025 and 13.8% in FY2024, reflecting higher cost of sales growth outpacing revenue growth.

• · Net sales growth accelerated to 77.8% in FY2026 from 46.6% in FY2025.
• · Cost of sales grew 78.3% in FY2026, slightly outpacing revenue growth and contributing to margin compression.
• · Operating expenses as a percentage of net sales improved to 3.7% in FY2026 from 5.4% in FY2025 and 5.7% in FY2024.
• · Interest expense increased 226.5% to $194.6M in FY2026 from $59.6M in FY2025, while interest income rose 212.5% to $186.9M.
• · Income tax provision surged 254.8% to $556.3M in FY2026, with the effective tax rate becoming more negative at -19.9% vs -12.9% in FY2025.
• · Net income declined 9.0% in FY2025 compared to FY2024, before rebounding strongly in FY2026.

31-08-2026

Core University Living Real Estate Income Trust filed its quarterly report (10-Q) for the period ending June 30, 2026. The company reports total assets of $1,000, consisting entirely of cash and cash equivalents, with no liabilities and no equity, as all shareholder interests are classified as redeemable common shares. The filing indicates the company is in an early or dormant operational stage with minimal financial activity.

• · The company has no liabilities and no equity, with all shareholder funding classified as redeemable common shares.
• · The filing includes standard sections such as Management's Discussion and Analysis, Legal Proceedings, and Risk Factors, but no material changes or operations are indicated.

31-08-2026

Elventix Technology Corp filed its 10-K annual report for the fiscal year ended May 31, 2026, reporting its first full year of operations since inception in March 2025. The company generated $3,359 in revenue but recorded a net loss of $108,556, compared to a net loss of $199 in the prior period. Total assets grew to $255,343 from $215,038, while stockholders' equity turned negative to ($65,330) from $4,301, driven by the accumulated deficit and increased liabilities.

• · Operating expenses totaled $111,915 in FY2026, up from $199 in the prior period, driven primarily by $48,211 in amortization expense and $35,516 in professional fees.
• · Net cash used in operating activities was $56,056 in FY2026, compared to $199 in the prior period.
• · Net cash used in investing activities was $75,595 in FY2026, including $50,395 for capitalized software refactoring costs and $25,200 for capitalized website development costs.
• · Net cash provided by financing activities was $130,572 in FY2026, primarily from $117,185 in related party loan proceeds and $38,925 from common stock issuance.
• · The company had a net operating loss carry-forward of $108,755 as of May 31, 2026, with a full valuation allowance of $22,838 against the deferred tax asset.
• · Total liabilities increased 52.2% to $320,673, including $163,000 in promissory note payable and $139,384 in long-term related party loan payable.
• · The company's accumulated deficit grew to $108,755 from $199, reflecting the net loss for the year.

31-08-2026

Stimcell Energetics Inc. filed its 10-K annual report for the year ended May 31, 2026, reporting a net loss of $895,375, a 58.1% increase from the prior year's loss of $566,293. Total operating expenses surged 58.2% to $826,027, driven by a 226.8% jump in R&D costs and a 79.2% increase in G&A expenses, while consulting and management fees remained nearly flat. The company's working capital deficit widened 45.3% to $1,811,320, and cash used in operations more than doubled to $312,081, leaving cash on hand at just $3,057.

• · Cash balance fell 79.0% to $3,057, down from $14,581 at May 31, 2025.
• · Current assets increased 283.8% to $81,454, but current liabilities grew 49.3% to $1,892,774, widening the working capital deficit.
• · Financing activities provided $300,582 in FY 2026, up from $112,858 in FY 2025, primarily from related-party notes.
• · Shares outstanding increased by 1,000,000 shares (from 20,141,272 to 21,141,272) due to shares issued for services and future services.
• · Accumulated deficit grew to $11,756,931 from $10,861,556.
• · No debt forgiveness occurred in FY 2026, compared to $5,931 in FY 2025.